Pfizer (PFE) CEO Albert Bourla Buys 38,000 Shares

What Happened
Albert Bourla, Pfizer's Chairman & CEO and a director, made an open-market purchase of 38,000 shares of Pfizer common stock on August 12, 2026. The shares were acquired at $26.34 per share for a total transaction value of $1,000,920. This was a purchase (Form 4 transaction code P), which investors often view as a direct insider buy rather than a sale.

Key Details

• Transaction date: 2026-08-12
• Shares purchased: 38,000
• Price per share: $26.34
• Total value: $1,000,920
• Transaction type/code: Open-market purchase (P)
• Filing date: 2026-08-12 (filed same day as the transaction)
• Shares owned after transaction: not specified in the summary provided — see the full Form 4 for updated ownership totals
• Footnotes / trading plan: no 10b5-1 plan or other special footnotes were disclosed in the information provided
• Accession number for the filing: 0001225208-26-007083

Context
Insider purchases are often watched by retail investors as a potential sign of confidence, though they do not prove future stock performance. This report documents a straightforward open-market buy by the CEO; no option exercise, gift, or immediate sale was noted in the provided details. For the complete filing and exact post-transaction holdings, consult the SEC Form 4 linked by the accession number above.